Analysts Set Akero Therapeutics, Inc. (NASDAQ:AKRO) PT at $76.29
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) has received a consensus recommendation of “Buy” from the nine research firms that are covering the company, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have covered the stock in the last year […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) has received a consensus recommendation of “Buy” from the nine research firms that are covering the company, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have covered the stock in the last year […]
